Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human MAVS Antibodies:
anti-Mouse (Murine) MAVS Antibodies:
anti-Rat (Rattus) MAVS Antibodies:
Go to our pre-filtered search.
Human Monoclonal MAVS Primary Antibody for ICC, IP - ABIN1169132
Michallet, Meylan, Ermolaeva, Vazquez, Rebsamen, Curran, Poeck, Bscheider, Hartmann, König, Kalinke, Pasparakis, Tschopp: TRADD protein is an essential component of the RIG-like helicase antiviral pathway. in Immunity 2008
Show all 3 Pubmed References
Human Polyclonal MAVS Primary Antibody for IHC (p), WB - ABIN2477103
Neubauer, Newell, Ingwall: Metabolic consequences and predictability of ventricular fibrillation in hypoxia. A 31P- and 23Na-nuclear magnetic resonance study of the isolated rat heart. in Circulation 1992
Show all 3 Pubmed References
Mouse (Murine) Polyclonal MAVS Primary Antibody for WB - ABIN1881530
Ichinohe, Pang, Iwasaki: Influenza virus activates inflammasomes via its intracellular M2 ion channel. in Nature immunology 2010
Human Polyclonal MAVS Primary Antibody for ELISA, IF - ABIN4332859
Klarquist, Hennies, Lehn, Reboulet, Feau, Janssen: STING-mediated DNA sensing promotes antitumor and autoimmune responses to dying cells. in Journal of immunology (Baltimore, Md. : 1950) 2014
The authors determined that porcine reproductive and respiratory syndrome virus 3C protease cleaved MAVS at Glu268.
Real-time quantitative PCR analysis indicated that Tibetan porcine IPS-1 (show ISYNA1 Antibodies) mRNA was most abundant in the liver and kidney.
findings reveal a negative feedback loop of RLR (show DHX58 Antibodies) signaling generated by Tetherin (show BST2 Antibodies)-MARCH8 (show MARCH8 Antibodies)-MAVS-NDP52 (show CALCOCO2 Antibodies) axis and provide insights into a better understanding of the crosstalk between selective autophagy and optimal deactivation of type I IFN signaling.
Studied association of genetic variants of the MAVS, MITA and MFN2 genes with leprosy in Han Chinese from Southwest China; found no association between the variants and susceptibility to leprosy.
Mechanistic studies showed that HACE1 (show HACE1 Antibodies) exerts its inhibitory role on virus-induced signaling by disrupting the MAVS-TRAF3 (show TRAF3 Antibodies) complex.
this study shows that keratinocytes are an important source of IFN-beta (show IFNB1 Antibodies) and MAVS is critical to this function, and demonstrates how the epidermis triggers unwanted skin inflammation under disease conditions
Herpes simplex virus 1 blocks MAVS-Pex (show PHEX Antibodies) mediated early interferon (show IFNA Antibodies)-stimulated gene activation through VP16 to dampen the immediate early (show JUN Antibodies) antiviral innate immunity signaling from peroxisomes.
This study demonstrates a novel pathway for elevated IFNbeta signaling in SLE that is not dependent on stimulation by immune complexes but rather is cell intrinsic and critically mediated by IFNbeta and MAVS.
TTLL12 as a negative regulator of RNA-virus-induced type I IFN expression by inhibiting the interaction of VISA with other proteins.
Therefore, Seneca Valley virus suppressed antiviral interferon (show IFNA Antibodies) production to escape host antiviral innate immune responses by cleaving host adaptor molecules MAVS, TRIF (show TRIM69 Antibodies), and TANK by its 3C protease.
GPATCH3 interacts with VISA and disrupts the assembly of virus-induced VISA signalosome therefore acts as a negative regulator of RLR (show DHX58 Antibodies)-mediated innate antiviral immune responses.
this study shows that MAVS silencing upregulates IFN-beta (show IFNB1 Antibodies) production via upregulation of NF-kappaB (show NFKB1 Antibodies) and IRF3 (show IRF3 Antibodies) signaling
RIPK3 (show RIPK3 Antibodies) regulates type I IFN both transcriptionally, by interacting with MAVS and limiting RIPK1 (show RIPK1 Antibodies) interaction with MAVS, and post-transcriptionally.
Data suggest that activation of either RIG-I (show DDX58 Antibodies)/MAVS or STING pathways during acute intestinal tissue injury in mice resulted in IFN-I signaling that maintained gut (show GUSB Antibodies) epithelial barrier integrity and reduced GVHD severity.
this paper identifies TRIM31 (show TRIM31 Antibodies), an E3 ubiquitin ligase (show MUL1 Antibodies) of the TRIM (show TRAT1 Antibodies) family of proteins, as a regulator of MAVS aggregation
Taken together, these results suggest that MAVS is essential for boosting optimal primary CD4 (show CD4 Antibodies)(+) T cell responses upon NS4B-P38G West Nile virus vaccination and yet is dispensable for host protection and recall T cell responses during secondary wild-type West Nile virus infection.
this study demonstrates that the capacity of hepatitis A virus to evade MAVS-mediated type I interferon (show IFNA Antibodies) responses defines its host species range.
Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signaling response.
Rotavirus infection in macrophages depend on MAVS but not involve the NLRP3 (show NLRP3 Antibodies) inflammasome nor JNK (show MAPK8 Antibodies) and p38 (show CRK Antibodies) signal pathway.
MARCH5 (show MARCH5 Antibodies) binds MAVS only during viral stimulation when MAVS forms aggregates, and these interactions require the RING domain of MARCH5 (show MARCH5 Antibodies) and the CARD domain of MAVS.
An autoinhibitory mechanism modulates MAVS activity in unstimulated cells and, on viral infection, individual regions of MAVS are released following MAVS filament formation to activate antiviral signalling cascades.
This gene encodes an intermediary protein necessary in the virus-triggered beta interferon signaling pathways. It is required for activation of transcription factors which regulate expression of beta interferon and contributes to antiviral immunity. Multiple transcript variants encoding different isoforms have been found for this gene.
virus-induced signaling adapter
, mitochondrial antiviral-signaling protein
, mitochondrial IFN-beta promoter stimulator 1
, IP6 kinase
, VIP1 homolog
, histidine acid phosphatase domain containing 2A
, histidine acid phosphatase domain-containing protein 2A
, inositol hexakisphosphate and diphosphoinositol-pentakisphosphate kinase 1
, inositol pyrophosphate synthase 1
, insP6 and PP-IP5 kinase 1
, CARD adapter inducing interferon beta
, CARD adaptor inducing IFN-beta
, IFN-B promoter stimulator 1
, interferon beta promoter stimulator protein 1
, putative NF-kappa-B-activating protein 031N
, virus-induced signaling adaptor
, virus-induced-signaling adapter
, IFN-beta promoter stimulator-1
, mitochondrial anti-viral signaling protein
, interferon-beta promoter stimulator protein 1